A systematic review of postcoital bleeding and risk of cervical cancer
- PMID: 16762128
- PMCID: PMC1839021
A systematic review of postcoital bleeding and risk of cervical cancer
Abstract
Background: Postcoital bleeding may be a symptom of cervical cancer. Guidance to aid a GP in determining whom to investigate or refer exists but recommendations vary. Women need to be involved in decisions about their care and this involves communicating risk and an exploration of the implications of the risk. Risk estimates of postcoital bleeding for cervical cancer are not available.
Aim: To provide an estimate of the positive predictive values of postcoital bleeding for cervical cancer to aid decision making in primary care about whom to investigate for cervical cancer.
Design of study: A systematic review.
Setting: Community, primary and secondary care.
Method: Six electronic databases were searched from the beginning of each of their time frames. Inclusion criteria were that the study was published in English and reported or contained enough data to calculate the prevalence or incidence of postcoital bleeding within the study population. No studies were excluded on issues of methodological quality.
Results: The search strategy identified 910 unique articles. The point prevalence of postcoital bleeding in the community ranged from 0.7 to 9% among women. One study reported an annual cumulative incidence of 6% of menstruating women. The prevalence of postcoital bleeding in women with cervical cancer ranged from 0.7 to 39%. Calculation of risk that a woman in the community developing postcoital bleeding has cervical cancer ranges from 1 in 44,000 at age 20-24 years to 1 in 2 400 aged 45-54 years. There was no information allowing the direct calculation of risk in women presenting to primary care.
Conclusion: The evidence base for management strategies of postcoital bleeding and calculations of risk for cervical cancer in women with postcoital bleeding are poor. Recommendations for clinical practice are made on the current evidence.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. doi: 10.1002/14651858.CD002126.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. PMID: 16235297 Updated.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
Cited by
-
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.Cells. 2022 Jul 11;11(14):2170. doi: 10.3390/cells11142170. Cells. 2022. PMID: 35883612 Free PMC article.
-
Postcoital bleeding.CMAJ. 2023 Sep 11;195(35):E1180. doi: 10.1503/cmaj.230143. CMAJ. 2023. PMID: 37696551 Free PMC article. No abstract available.
-
Saignement postcoïtal.CMAJ. 2023 Dec 17;195(49):E1735. doi: 10.1503/cmaj.230143-f. CMAJ. 2023. PMID: 38110214 Free PMC article. French. No abstract available.
-
Achieving earlier diagnosis of symptomatic cervical cancer.Br J Gen Pract. 2014 Oct;64(627):495-6. doi: 10.3399/bjgp14X681649. Br J Gen Pract. 2014. PMID: 25267024 Free PMC article. No abstract available.
-
Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.Cochrane Database Syst Rev. 2015 May 1;2015(5):CD011000. doi: 10.1002/14651858.CD011000.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2019 Mar 19;3:CD011000. doi: 10.1002/14651858.CD011000.pub3. PMID: 25932968 Free PMC article. Updated.
References
-
- Pengiran Tengah DSNA, Byrne PO, Wills AJ. Urgent 2-week referrals for CNS/Brain tumours: a retrospective audit. Clin Oncol (R Coll Radiol) 2003;15:7–9. - PubMed
-
- Morrison J, Gillespie S, MacKenzie IZ. ‘Two week wait’ standards for suspected gynaecological malignancy. On target but missing the point? Journal of the British Menopause Society. 2003;(December):170–172. - PubMed